A detailed history of Acadian Asset Management LLC transactions in Immunocore Holdings PLC stock. As of the latest transaction made, Acadian Asset Management LLC holds 860 shares of IMCR stock, worth $25,094. This represents 0.0% of its overall portfolio holdings.

Number of Shares
860
Holding current value
$25,094
% of portfolio
0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$30.06 - $41.49 $25,851 - $35,681
860 New
860 $26,000
Q2 2023

Aug 07, 2023

SELL
$48.54 - $61.64 $3.08 Million - $3.91 Million
-63,457 Reduced 99.99%
6 $0
Q1 2023

May 11, 2023

SELL
$46.12 - $65.71 $9.52 Million - $13.6 Million
-206,422 Reduced 76.49%
63,463 $3.13 Million
Q4 2022

Feb 14, 2023

BUY
$45.51 - $65.08 $3.89 Million - $5.56 Million
85,420 Added 46.31%
269,885 $15.4 Million
Q3 2022

Nov 14, 2022

BUY
$37.34 - $57.44 $6.89 Million - $10.6 Million
184,465 New
184,465 $8.65 Million

Others Institutions Holding IMCR

About Immunocore Holdings plc


  • Ticker IMCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,897,100
  • Market Cap $1.28B
  • Description
  • Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...
More about IMCR
Track This Portfolio

Track Acadian Asset Management LLC Portfolio

Follow Acadian Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.